Understanding Cryopreservation throughout the iPSC Differentiation and Manufacturing Process

Time: 2:30 pm
day: Day 2 PM


  • Clarifying the need for cryopreservation at various steps of iPSC manufacture
  • Development of cryopreservation unit operations to ensure a high level of consistency for allogeneic cell therapies
  • Optimizing formulation of drug product based on post thaw quality attributes, clinical tolerance, and process capabilities